Noradrenaline contractions of human prostate mediated by α1c‐(α1c‐) adrenoceptor subtype

I Marshall, RP Burt, CR Chappie - British journal of …, 1995 - Wiley Online Library
1 The subtype of α1‐adrenoceptor mediating contractions of human prostate to
noradrenaline was characterized by use of a range of competitive and non‐competitive …

RBx 6198: A novel α1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia

K Nanda, KS Naruganahalli, S Gupta… - European journal of …, 2009 - Elsevier
The present study, investigates the effect of RBx 6198, 2-{3-[4-(2-Isopropoxy-phenyl)-
piperazin-1-yl]-propyl}-3a, 4, 7, 7a-tetrahydro-isoindole-1, 3,-dione, a novel α1-adrenoceptor …

KMD-3213, a novel α1A-adrenoceptor antagonist, potently inhibits the functional α1-adrenoceptor in human prostate

N Moriyama, K Akiyama, S Murata, J Taniguchi… - European journal of …, 1997 - Elsevier
KMD-3213,(−)-(R)-1-(3-hydroxypropyl)-5-[2-[[2-[2-(2, 2, 2-trifluoroethoxy) phenoxy] ethyl]
amino] propyl] indoline-7-carboxamide, is a novel and selective α1A-adrenoceptor …

RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy) ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor …

AP Ford, NF Arredondo, DR Blue, DW Bonhaus… - Molecular …, 1996 - ASPET
Norepinephrine (NE) contracts smooth muscle cells within the human lower urinary tract
(LUT)(bladder neck, prostate, and urethra). Receptor distribution and pharmacological …

Section Review Central & Peripheral Nervous Systems: α1-Adrenoceptor antagonists as treatments for benign prostatic hyperplasia

B Kenny, A Collis, A Naylor, M Wyllie - Expert Opinion on …, 1995 - Taylor & Francis
α1-Adrenoceptor antagonists, originally targeted towards hypertension, are being
increasingly used in the treatment of benign prostatic hyperplasia. The identification of …

An investigation of the uroselective properties of four novel α1a-adrenergic receptor subtype-selective antagonists

VL Pulito, X Li, SS Varga, LS Mulcahy, KS Clark… - … of Pharmacology and …, 2000 - ASPET
The development of α 1a-adrenergic receptor (AR) subtype-selective antagonists is likely to
result in uroselective agents that effectively treat benign prostatic hyperplasia (BPH) …

Subtype selective α1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia

C Forray, SA Noble - Expert Opinion on Investigational Drugs, 1999 - Taylor & Francis
Benign prostatic hyperplasia (BPH) is highly prevalent in the male population beyond the
age of 60. Impairment of urinary flow due to prostate enlargement gives rise to symptoms of …

New alpha 1-adrenoceptor antagonist, JTH-601, shows more than 10 times higher affinity for human prostates than arteries

M TAKAHASHI, T TANIGUCHI, S MURATA… - The Journal of …, 1999 - Elsevier
PURPOSE: We compared the affinities of a new alpha1-adrenoceptor (AR) antagonist, JTH-
601 with those of several alpha1-AR antagonists in human prostates and arteries …

Pharmacological evidence that different a1 adrenoceptor subtypes mediate contraction in rabbit prostate and hypogastric artery

S Delaflotte, M Auguet… - Acta physiologica …, 1996 - Wiley Online Library
The α1‐adrenoceptor subtypes mediating contraction of rabbit prostate and hypogastric
artery were pharmacologically characterized using an isolated organ bath technique. The …

Localization of mRNA and receptor binding sites for the alpha sub 1a-adrenoceptor subtype in the rat, monkey and human urinary bladder and prostate

PD Walden, MM Durkin, H Lepor, JM Wetzel… - The Journal of …, 1997 - auajournals.org
Purpose: To localize the mRNAs and receptor binding sites for the alpha sub 1a/A,
alpha1b/B and alpha1d/D-adrenoceptor (AR) subtypes in the rat, monkey and human …